Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Biosight

Biosight

Series C
Karmiel, IsraelFounded 1999Nov 2020
Healthtech

Biosight raised €16M in a Series C round in Nov 2020. The company is based in Karmiel, Israel. Investors in the round: Israel Biotech Fund. Data as of Nov 2026.

← Biosight
Amount raised
€16M
€16,306,214
Native amount
19,000,000 USD
Stage
Series C
series c
Investors
1

Provenance & confidence

High confidence
Amount
19,000,000 USD
ECB-at-date → €16M · rate 1.1652 on 2020-11-02
High confidence
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1 named
Israel Biotech Fund
Date
Nov 2020
Round type
series c
Amount (EUR)
€16M

Other rounds

same company

Related news